Since PD-L1-mediated T cell exhaustion emerges following anticancer treatments, some studies proposed combination of PD-1/PD-L1 blockade with conventional therapies to unleash cytotoxic T cells as well as to inhibit tumor cell proliferation. This evidence concerns the gene CD274 and neoplasm.